These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16949366)

  • 1. Structure of an Hsp90-Cdc37-Cdk4 complex.
    Vaughan CK; Gohlke U; Sobott F; Good VM; Ali MM; Prodromou C; Robinson CV; Saibil HR; Pearl LH
    Mol Cell; 2006 Sep; 23(5):697-707. PubMed ID: 16949366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase.
    Verba KA; Wang RY; Arakawa A; Liu Y; Shirouzu M; Yokoyama S; Agard DA
    Science; 2016 Jun; 352(6293):1542-7. PubMed ID: 27339980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G; Verkhivker GM
    J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
    Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
    J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
    Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
    Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
    Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
    Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.
    Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA
    Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
    Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
    J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4.
    Zhao Q; Boschelli F; Caplan AJ; Arndt KT
    J Biol Chem; 2004 Mar; 279(13):12560-4. PubMed ID: 14701845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
    Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
    J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.
    Stepanova L; Leng X; Parker SB; Harper JW
    Genes Dev; 1996 Jun; 10(12):1491-502. PubMed ID: 8666233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
    Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
    J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Mechanisms of Communication Switching in the Hsp90-Cdc37 Regulatory Complexes with Client Kinases through Allosteric Coupling of Phosphorylation Sites: Perturbation-Based Modeling and Hierarchical Community Analysis of Residue Interaction Networks.
    Stetz G; Astl L; Verkhivker GM
    J Chem Theory Comput; 2020 Jul; 16(7):4706-4725. PubMed ID: 32492340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
    Vaughan CK; Mollapour M; Smith JR; Truman A; Hu B; Good VM; Panaretou B; Neckers L; Clarke PA; Workman P; Piper PW; Prodromou C; Pearl LH
    Mol Cell; 2008 Sep; 31(6):886-95. PubMed ID: 18922470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM; Kretzschmar A; Richter K
    J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function.
    Wang L; Li L; Gu K; Xu XL; Sun Y; You QD
    Curr Drug Targets; 2017; 18(13):1572-1585. PubMed ID: 27231111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties.
    Jiang F; Wang HJ; Bao QC; Wang L; Jin YH; Zhang Q; Jiang D; You QD; Xu XL
    Bioorg Med Chem; 2016 Nov; 24(21):5431-5439. PubMed ID: 27647369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.